According to findings from the National Institute of Mental Health's Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD), two-thirds of patients with bipolar I or II depressive syndromes have concomitant manic symptoms, typically distractibility, flight of ideas or racing thoughts and psychomotor agitation [28]
Available from: Miller MJ, et al
Drugs 82, 12131220
A.AndraeJ.AndoK.Del GaudioF.et al
For definitive verification, submit a sample to an independent analytical laboratory for identity testing
For assessment of glucose-induced insulin secretion, glucose was given orally at a dose of 4 g kg 1 in 6 h fasted mice, followed by blood sampling at timepoints 0, 2, 5, 15 and 30 min after glucose administration